Literature DB >> 14580772

Comparative cytogenetic and DNA flow cytometric analysis of 242 primary breast carcinomas.

Adewale Adeyinka1, Bo Baldetorp, Fredrik Mertens, Håkan Olsson, Oskar Johannsson, Sverre Heim, Nikos Pandis.   

Abstract

The cytogenetic and DNA flow cytometric findings in 242 breast carcinomas were compared. The combined use of both techniques improved the detection of abnormal cell populations from 65% by cytogenetic analysis alone and 59% by DNA flow cytometric analysis alone to 84%. Informative and comparable cytogenetic and flow cytometric data were obtained for 155 tumors. Among these 155 tumors, there was good concordance (64%) between the estimates of genomic changes by the two methods. Most discrepancies were among the DNA-diploid cases, where cytogenetic analysis detected small genomic changes. There were, however, also some exceptions in which large genomic changes detected by one method were missed by the other. Of the specific breast cancer-associated cytogenetic aberrations subjected to separate correlation analysis, polysomy for chromosome 20 was significantly associated with a high S-phase fraction, whereas loss of the long arm of chromosome 16 and/or the presence of a der(1;16) were significantly associated with a low S-phase fraction. Our data show that cytogenetic and DNA flow cytometric analyses of breast carcinomas give largely comparable results, and that combining data from both methods significantly improves the information obtained by either technique used alone on the genetic abnormalities in these tumors.

Entities:  

Mesh:

Year:  2003        PMID: 14580772     DOI: 10.1016/s0165-4608(03)00190-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis.

Authors:  Lydia Nakopoulou; Effie G Panayotopoulou; Ioanna Giannopoulou; Ioanna Tsirmpa; Sophia Katsarou; Eleni Mylona; Paraskevi Alexandrou; Antonios Keramopoulos
Journal:  J Clin Pathol       Date:  2007-07       Impact factor: 3.411

2.  Can the centrosome be a marker for DNA ploidy in breast cancer?

Authors:  Rita A Sakr; Jocelyne Fleury; Claudie Prengel; Jean-Francois Bernaudin; Serge Uzan; Roman Rouzier; Emile Darai
Journal:  J Cytol       Date:  2012-04       Impact factor: 1.000

3.  Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.

Authors:  Timour Baslan; Jude Kendall; Konstantin Volyanskyy; Katherine McNamara; Hilary Cox; Sean D'Italia; Frank Ambrosio; Michael Riggs; Linda Rodgers; Anthony Leotta; Junyan Song; Yong Mao; Jie Wu; Ronak Shah; Rodrigo Gularte-Mérida; Kalyani Chadalavada; Gouri Nanjangud; Vinay Varadan; Assaf Gordon; Christina Curtis; Alex Krasnitz; Nevenka Dimitrova; Lyndsay Harris; Michael Wigler; James Hicks
Journal:  Elife       Date:  2020-05-13       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.